MEDTRONIC, INC. · Coronary Drug-Eluting Stent · First cleared Feb 2012
Total Reports
1,762
Reports (30d)
7
Active Signals
1
Open Recalls
0
What the reports describe · Claripulse analysis
In Vivo Stent Deformation During Advancement
onyx frontier, procedure involving, coronary drug, onyx, frontier
18
reports
Problem groupings are generated by Claripulse from report narrative text. They summarize what reporters wrote, not adjudicated root cause.
Detection
Evidence
Three contemporary thin‐strut drug‐eluting stents implanted in severely calcified coronary lesions of participants in a randomized all‐comers trial
Rosaly A. Buiten, et al. · Catheterization and Cardiovascular Interventions · 2020
Non-Inferiority of Resolute Integrity Drug-Eluting Stent to Benchmark Xience Drug-Eluting Stent.
Nakamura M, et al. · 2018
Three-year clinical outcomes between Endeavor Resolute® and Resolute Integrity® Zotarolimus-Eluting Stents in an Asian population
Yong Hoon Kim · The Anatolian Journal of Cardiology · 2020
Three-year clinical outcome of biodegradable hybrid polymer Orsiro sirolimus-eluting stent and the durable biocompatible polymer Resolute Integrity zotarolimus-eluting stent: A randomized controlled trial.
Kim SH, et al. · 2019
Comparison of the Major Clinical Outcomes for the Use of Endeavor® and Resolute Integrity® Zotarolimus-Eluting Stents During a Three-Year Follow-up.
Kim YH, et al. · 2020
Citations indexed from PubMed.
Keep exploring
Perclose ProGlide
ABBOTT VASCULAR INC. · 24,504 reports
Perclose ProStyle
ABBOTT VASCULAR INC. · 19,336 reports
PERCLOSE
ABBOTT VASCULAR INC. · 9,890 reports
Angio-Seal
TERUMO MEDICAL CORPORATION · 6,417 reports
SYNERGY
BOSTON SCIENTIFIC CORPORATION · 5,991 reports
Resolute Onyx
MEDTRONIC, INC. · 4,467 reports
Claripulse monitors these devices weekly and detects anomalies using 6 statistical methods — spike, trend, changepoint, peer-outlier, and more. 1 active signal detected right now.
Get Early AccessUnderstanding this data
